Group President, Pharma and Consumer Health · Catalent, Inc. (CLT)

Aristippos Gennadios

A named executive officer of Catalent in every fiscal year CompBrief holds from FY2022 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$3,799,557

Salary $600,000Stock awards $2,700,277

FY2022: $2,125,504

4th of 7 named executive officers at Catalent by FY2023 total.

7 named officers on file for Catalent, FY2023

Aristippos Gennadios’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 5 equity grants, each cited to its filing
  • CLT’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Catalent’s whole pay program stands against its peers

  • Catalent’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CLT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed December 15, 2023 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Aristippos Gennadios’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Aristippos Gennadios compensation by year

Catalent Summary Compensation Table · all 2 fiscal years held
In US dollars, as Catalent reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023
Salary$485,769$600,000
Bonus$0$0
Stock awards$850,275$2,700,277
Option awards$150,008$300,017
Non-equity incentive$572,240$135,000
Pension and deferred compensation$0$0
All other$67,212$64,263
Total$2,125,504$3,799,557

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Catalent, Inc. DEF 14A filed December 15, 2023, accession 0001193125-23-295996, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Catalent, Inc. filed document, accession 0001193125-23-295996. Every figure is read from that document and cited to the page and table it appears in. Filed December 15, 2023.

$2.1M
$3.8M
FY22
FY23
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU18,689$810,355—
RSU4,017$174,177—
RSU1,859$80,606—
RSU1,505$65,257—
PSU1,264$54,807—
PSU1,162$50,384—
RSU1,136$49,257—
RSU885$38,374—
PSU574$24,889—
PSU554$24,021—
Option8,078—$107.63
Option3,435—$113.00

Per the Outstanding Equity Awards at Fiscal Year-End table in Catalent, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 14 award rows shown.

Insider transactions since the last proxy

6 Form 4 lines since the FY2023 proxy (filed December 15, 2023)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2024-12-18Disposition to the issuer—113,724—0
2024-12-18Grant or award—21,562$0.0021,562
2024-12-18Disposition to the issuer—21,562—0
2024-08-02Sale—1,169$59.55113,724
2024-07-29Sale—349$58.70114,893
2024-07-26Grant or award—18,746$0.00115,242

The 6 most recent of 6 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Catalent’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Alessandro MaselliPresident and Chief Executive Officer$6,583,672
John ChiminskiFormer Executive Chair$4,807,767
Manja BoermanFormer President, Division Head for Biomodalities$3,979,888
Aristippos Gennadios · this pageGroup President, Pharma and Consumer Health$3,799,557
Thomas CastellanoFormer Senior Vice President and Chief Financial Officer$2,729,983
Steven FasmanFormer Executive Vice President & Chief Administrative Officer$2,310,299
Ricky HopsonPresident, Division Head for Clinical Development & Supply and Former Interim Chief Financial Officer$972,307

The full Catalent compensation record

free company brief

This page is one person within Catalent's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Catalent's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Aristippos Gennadios's compensation dossier · One-time report. No refunds.